Amit Gupta – Pharmat Sas
View Detailed Executive Profile →Professional Overview
- Amit Gupta founded Pharmat Technology in February 2021, leading innovation and development in the pharmaceutical sector.
- Served as DGM at Alembic Pharmaceuticals Limited from April 2019 to February 2022, contributing significantly to product development and operational efficiency.
- Held the position of Assistant Manager at Intas Pharmaceuticals from August 2012 to April 2013, gaining valuable experience in pharmaceutical management and operations.
- At Pharmat Technology, focused on leveraging technology to enhance drug delivery systems and improve patient outcomes.
- Successfully transitioned Pharmat Technology into a competitive player in the pharmaceutical technology landscape.
- Faced challenges in establishing a startup amidst a competitive market, requiring strategic planning and robust product development.
- Continued engagement with industry stakeholders to foster collaborations and further research initiatives within the pharmaceutical field.
- Amit Gupta's trajectory reflects a commitment to advancing pharmaceutical technologies and improving healthcare solutions.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Intas Pharmaceuticals | Assistant Manager | Aug 2012 – Apr 2013 |
| Alembic Pharmaceuticals Limited | DGM | Apr 2019 – Feb 2022 |
| Pharmat Technology | Founder | Feb 2021 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Pharmat Sas corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Amit Gupta's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Pharmat Sas's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)